ClinicalTrials.gg
Not yet recruitingNCT07402733PIC RehabUpdated Jun 1, 2026

Psychologically Informed Cervicovestibular Rehabilitation (PIC Rehab) for Mild Traumatic Brain Injury: A Feasibility Trial

A Phase 1 interventional study of Psychologically Informed CVPT (PIC) Rehab and Cervicovestibular Rehabilitation (CVPT) in Mild Traumatic Brain Injury, Concussion, sponsored by Sport Injury Prevention Research Centre. Not yet recruiting at 1 site in Canada. Open to participants aged 18 Years to 70 Years. Per ClinicalTrials.gov, last updated 2026-06-01.

Sponsored by Sport Injury Prevention Research Centre · Phase 1, Interventional, and Treatment

Phase
Phase 1
Study type
Interventional
Enrollment
34
Allocation
Non-randomized
Ages
18 Years to 70 Years
Sex
All
01

Study summary

Mild traumatic brain injuries ("mTBIs") affect over 480,000 Canadians each year. While many individuals recover in the initial 4 weeks following mTBI, in up to 30% of individuals symptoms and functional impairments often persist leading to significant disability, decreased quality of life and participation in education, physical and occupational related activities. An assessment that evaluates multiple systems is recommended for individuals with mTBI, often involving multiple health care professionals to assess different areas of function (e.g. oculomotor, vestibular, balance, mood, cognition, etc). Current evidence supports the use of cervicovestibular rehabilitation (CVPT) (which includes physiotherapy techniques aimed at treating the neck, balance, visual and other sensory systems) and symptom-tolerated exercise. Evidence suggests that collaborative care, cognitive behavioural therapy (CBT) may be of benefit. However, the added value of CVPT and CBT in combination co-designed by patients and community partners has not yet been evaluated in mTBI. In other pain and dizziness conditions, the addition of CBT to physical/vestibular rehabilitation yielded improved outcomes. Here we take a transdisciplinary team-based approach to evaluate an integrated combination of CVPT and CBT.

This study will recruit a total of 34 people ages 18-70 years old who have ongoing symptoms following an mTBI for more than two weeks. The first 17 patients will receive CVPT along and the second 17 patients will receive psychologically informed CVPT ("PIC" Rehab). This study will help determine if combined therapy has an additive effect on helping patients recovery from mTBI.

Read the detailed description

Problem: Mild traumatic brain injuries and concussions affect over 480,000 or 1.2% of Canadians each year.1-3 While many individuals recover in the initial 4 weeks following mTBI, up to 30% have persisting symptoms and functional impairments, leading to significant disability, decreased quality of life, and reduced participation in education, physical, and occupational related activities.

Dizziness, balance problems, headaches, and neck pain: Headaches and dizziness are consistently the most commonly reported symptoms following mTBI with estimates of up to 95% of individuals reporting headaches and 40-80% reporting dizziness. In a majority of cases, these symptoms are reported concurrently. Standing balance and dynamic balance deficits have consistently been identified following mTBI, some of which resolve early post-injury (within 3-5 days), while some balance problems remain for weeks to months following injury. Dizziness, balance problems, headaches, and neck pain are associated with greater odds of developing persisting symptoms. In addition, persisting dizziness, headaches, neck pain, and balance impairments can lead to decreased participation in recreational, social, occupational, and educational activities as well as lower quality of life. Decreased activity can, in turn, lead to significant morbidity due to secondary health complications. Therefore, treatments aimed at minimizing headaches, dizziness and balance problems following mTBI are urgently needed to minimize the public health burden of this commonly occurring injury.

Treatment of dizziness, balance problems, headaches, and neck pain following mTBI: Previous randomized controlled trials (RCTs) have identified large positive treatment effects following targeted cervical and vestibular rehabilitation (CVPT) for children, adolescents, and adults with dizziness, neck pain, and headaches following mTBI. These treatments are personalized, based on the individual's profile of specific impairments. CVPT includes treatments targeting neuromuscular and sensorimotor control in combination with manual therapy and soft tissue techniques as indicated. Specific rehabilitation exercises are gradually progressed, performed in combination with symptom-tolerated aerobic exercise, and eventually evolve to task, context, and/or sport specific exercises. From a mechanistic standpoint, the goal of this treatment is to facilitate sensorimotor integration (i.e. integration of visual, vestibular, proprioceptive input and resultant motor output) and either reweigh central balancing of stimuli to optimize function of these systems or up-regulate the use of alternate systems in the event that one of the sensory systems is not optimally operating. Recent international consensus recommendations and clinical practice guidelines recommend CVPT as a treatment that has some of the strongest evidence to date to facilitate recovery. However, up to 27% of individuals may not respond to CVPT5, necessitating other treatment options.

Cognitive Behavioural Therapy: For individuals with persisting symptoms following mTBI, evidence supports the use of cognitive behavioural therapy (CBT). CBT is a form of treatment that uses multiple non-pharmacological strategies including education, behavioural and cognitive strategies. This form of non-pharmacological treatment has demonstrated safety and efficacy for a number of different conditions including insomnia, depression, mental health, and more recently for mTBI. For individuals with chronic pain, improvements in anxiety and depressive symptoms have been demonstrated but no difference in pain intensity or pain catastrophizing has been found to date. Patient centred approaches are necessary to optimize effectiveness. In individuals with dizziness, the addition of CBT to physical and/or vestibular rehabilitation may yielded improved outcomes.

Thus, CVPT and CBT in combination may have additive effects for individuals with mTBI. Here we take a transdisciplinary team-based approach to evaluate an integrated combination of CVPT and CBT.

Objectives:

We will conduct a pilot trial using a stepped approach to evaluate the feasibility and patient perceptions of CVPT alone as compared to CVPT in combination with CBT (hereafter referred to as PIC Rehab, or psychologically-informed CVPT) on 1) symptom severity and 2) time to resolution of mTBI related symptoms in adults with symptoms for greater than 14 days following mTBI.

The specific objectives of this study are as follows:

Objective 1: Determine the feasibility of PIC Rehab; Objective 2: Generate preliminary estimates of effect for PIC Rehab on mTBI related symptom resolution compared to CVPT alone; Objective 3: Describe changes by sex in domain specific outcomes of PIC Rehab compared to CVPT alone.

We hypothesize that PIC Rehab will be feasible and will have a greater impact on resolution of symptoms for participants with concomitant anxiety, depression, patient specific functional disability, than CVPT alone.

Methods:

Thirty-four adults aged 18-70 years with symptoms of dizziness, neck pain and/or headaches for at least 14 days following mTBI who are referred for cervicovestibular physiotherapy with one or more impairments related to the vestibular, oculomotor, sensorimotor, cervical spine, neuromuscular control, will be invited to participate. The participants who are included in this study are those with impairments that have previously been shown to respond to cervicovestibular rehabilitation. Patients who have previously undergone a session of cervicovestibular physiotherapy will be excluded from the study. The first 15 participants will complete typical CVPT and the next "step" of the study will have the following 15 participants complete PIC Rehab. Participants will be recruited consecutively in the order they are referred/approached based on their initial symptom reports of headaches, dizziness and/or neck pain at the time of presentation to the clinic, inclusive of both sexes and all genders, with the aim to have equal numbers of male and female participants.

Participants will be eligible for participation if they are referred to or seek treatment at Evidence Sport and Spinal Therapy for cervicovestibular rehabilitation following mTBI. For the purposes of this pilot feasibility trial we will limit our recruitment to one clinic with multiple therapists to enable future study of a larger trial at multiple clinics and, thus, avoid the chance of contamination between control and intervention groups. Consent to contact will be obtained in clinic for those patients meeting the inclusion criteria as part of the initial intake to the clinic and a member of the research team will follow-up and contact the patient by phone.

Eligibility Screen: Patients who agree to be contacted will undergo an eligibility screen with questionnaires (e.g., PCSS) by telephone with a research assistant. If the patient meets the eligibility for the trial they will then be sent a consent form to review and sign online followed by the initial demographic forms, questionnaires and subsequently scheduled for the initial assessment. After completing the initial assessment, the RA will confirm eligibility. It is possible that participants may have pre-existing relationships with the researchers or clinicians that are part of the research team as participants will be recruited through community sport medicine and/or physiotherapy clinics. Thus, all potential participants will be made aware that their choice to participate in this study will in no way affect the care that they receive and that they are free to decline participation at any time.

Protocol:

Participants will be blinded to the hypothesis of the study and to the opposite treatment group to which they are assigned. Thus, two separate consent forms will be used in the study - one for each type of treatment received. Both treatment groups will be seen once weekly for 8 weeks or until the time of symptom resolution and medical clearance to return to sport/learn/occupation and outcomes will be repeated at the 8 week time point. All of the physiotherapists who are participating in the study will undergo a standard CVPT training course. Following recruitment of the initial 15 patients, all therapists will undergo and online and in person training course for PIC Rehab. To facilitate recruitment in a timely fashion and prevent delays between arms, the first 3 of 6 therapists who complete treatment with their participants will complete the PIC Rehab training and the second 3/6 will complete a later training course for PIC Rehab.

CVPT alone: The control intervention will be the typical standard of care of CVPT (Schneider et al 2014, 2018) including individualized cervical and vestibular rehabilitation based on the patient's presentation, including symptom-tolerated exercise.

PIC Rehab: The Psychological Informed-CVPT (PIC Rehab) intervention (modified from Herdman et al) will include education, goal setting, distraction techniques, reattribution of symptoms, relaxation, in vivo exposure, cognitive therapy and problem solving. Collaborative training for physiotherapist providing the PIC Rehab will occur with the study team (KS, NS, KOY, CP).

The stepped process of the treatments will minimize contamination by therapist knowing the principles of the PIC Rehab. Adherence to the intervention will be assessed using scheduled audio recordings of the treatment sessions (to measure therapist adherence to the protocol) and patient reports of completion of home exercises (patient adherence). As this is a pilot feasibility study, a sample of 30 participants (15 in each group) allowing for two drop outs per group based on previous studies done at our centre was deemed to be pragmatic with in a 6 month time frame.

Initial Assessment: The initial assessment will take approximately 90 minutes and participants will complete a series of in person outcomes with the study physiotherapist as listed below that are specific to domains that may be affected by concussion. Where relevant, additional questions and health history information and clinically relevant outcomes will be gathered in keeping with the current standard of care.

Follow-up appointments: All participants will complete a brief set of questionnaires on REDCap at the time of each follow-up appointment to capture current symptoms, completion of home program exercises and any additional treatment that has been undertaken since the time of the previous appointment. In the event that new symptoms are present, the relevant self report and in person clinical outcomes related to the specific symptoms will be repeated. Treating physiotherapists will complete an adherence questionnaire after each session and record all subcomponents of treatment individualized to the patient.

Outcome assessments: Outcome assessments, both self report and in person clinical outcomes, will be repeated 8 weeks after the initial baseline assessment. Following participation in the trial, participants and therapists will be invited to take part in semi-structured interviews to share their experiences as part of the trial, including barriers and facilitators to the rehabilitation protocols.

Outcomes:

Primary feasibility outcomes will include recruitment, retention rate, adverse events, clinical implementation barriers and facilitators faced, and adherence to protocol (therapist).

Secondary outcomes of recovery including time to resolution of symptoms (days) to inform a phase 2 clinical trial. In keeping with international recommendations, and exploratory outcomes that assess impairment specific factors that may change with treatment (i.e. cervical spine, vestibulo-ocular, dynamic balance, etc) will be included.

Secondary outcomes will include change in symptom severity scores on the PCSS (/132), time to resolution of symptoms (days), time to medical clearance to return to sport, learn and work (days) (as relevant) to inform a phase 2 clinical trial. These outcomes will be defined as per the latest international consensus recommendations (page 702). Return to work (RTW) will be defined in the same was as return-to-learn and will be defined as: return to pre-injury occupational activities with no new support, including occupational accommodations or modifications.

Exploratory outcomes are outcomes that are part of typical clinical care and will include impairment based/domain specific outcomes that are the current best available outcomes and aligned with previous trials in the area. All outcomes will also be described by sex. Exploratory outcomes will include the following:

  • Fear Avoidance Behaviour after Traumatic Brain Injury Questionnaire (FAB-TBI)
  • World Health Organization Disability Assessment Schedule (WHODAS) 2.0 12 item self-report version
  • Anxiety (Generalized Anxiety Disorder-7, GAD-7)
  • Depression (Personal Health Questionnaire-9, PHQ-9)
  • Sleep Screen
  • Post Concussion Symptom Scale from the Sport Concussion Assessment Tool 6 (SCAT6)
  • Test of Memory Malingering (TOMM)
  • Dizziness Handicap Inventory
  • Modified Dizziness Questionnaire
  • Neck Disability Index
  • Neck Pain Questionnaire
  • Patient Specific Functional Scale (PSFS)
  • Post Traumatic Headache Questionnaire
  • Subjective Units of Discomfort Scale (SUDS)
  • Neurological screen including cranial nerve, cerebellar and long track signs
  • Cervical Spine: Cervical Spine range of motion, cervical flexor endurance, cervical flexion rotation test, craniocervical flexion test, manual spinal examination, palpation for segmental tenderness, extension rotation test, palpation of tender trigger points, palpation of greater and lesser occipital nerves
  • Tests done with fixation removed including spontaneous nystagmus, gaze evoked, fixation, hyperventilation, intracranial pressure, head shaking, positional testing (including Dix-Hallpike and Roll tests right and left).
  • Vestibulo-ocular reflex tests: head thrust test, dynamic visual acuity
  • Quantified Vestibular Ocular Motor Screen (qVOMS)
  • Motion sensitivity Test
  • Dynamic Balance: functional gait assessment (FGA) and advanced FGA
  • Balance Error Scoring System (BESS)
  • Buffalo Concussion Treadmill Test (BCTT) or Bike Test (BCBT) as appropriate depending on the patient preference
  • Orthostatic Vital Signs

Data Analysis:

Primary feasibility outcomes will be summarized using descriptive statistics [means (standard deviations) or medians/modes (ranges or interquartile ranges) or proportions] as appropriate. Secondary outcomes will be summarized descriptively by treatment group. In addition, exploratory Kaplan Meier survival analysis curves will be constructed by group for time to resolution of symptoms, return to sport, learn, occupation will be evaluated using Kaplan Meier survival analysis curves with the outcome of 8 weeks. Exploratory outcomes will be described by treatment group and sex using descriptive statistics as appropriate based on the outcome and the distribution of the data. Thematic analysis will be used to evaluate barriers and facilitators to PIC Rehab for both participants and providers.

02

Conditions studied

  • Mild Traumatic Brain Injury, Concussion

Browse trials for

Keywords

  • rehabilitation
  • cervical spine
  • vestibular
  • cognitive behavioural therapy
  • treatment
03

In context

Brain Concussion

637 studies on the registry are indexed under Brain Concussion; 163 are open to participants now.

This study's planned enrollment of 34 is below the median of 63 across 446 interventional studies indexed under Brain Concussion.

Browse Brain Concussion studies →

Lead sponsor

Sport Injury Prevention Research Centre is the lead sponsor of 12 studies on the registry; 3 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 70 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Reporting dizziness, neck pain and/or headaches for at least 14 days following mild traumatic brain injury/concussion who are referred for cervicovestibular physiotherapy with one or more impairments related to the vestibular, oculomotor, sensorimotor, cervical spine, neuromuscular control.

Exclusion criteria

Exclusion Criteria:

  • Patients who have previously undergone a session of cervicovestibular physiotherapy will be excluded
05

Study design

Phase
Phase 1
Primary purpose
Treatment
Allocation
Non-randomized
Intervention model
Parallel assignment
Masking
Single (Participant)
Enrollment
34 participants (estimated)

Study arms

  • Active comparator
    Cervicovestibular Rehabilitation (CVPT)

    CVPT includes treatments targeting neuromuscular and sensorimotor control in combination with manual therapy and soft tissue techniques as indicated.5 16 Specific rehabilitation exercises are gradually progressed, performed in combination with symptom-tolerated aerobic exercise, and eventually evolve to task, context, and/or sport specific exercises.16 From a mechanistic standpoint, the goal of this treatment is to facilitate sensorimotor integration (i.e. integration of visual, vestibular, proprioceptive input and resultant motor output) and either reweigh central balancing of stimuli to optimize function of these systems or upregulate the use of alternate systems in the event that one of the sensory systems is not optimally operating.5 17 Recent international consensus recommendations and clinical practice guidelines recommend CVPT as a treatment that has some of the strongest evidence to date to facilitate recovery.14 18

    Behavioral: Cervicovestibular Rehabilitation (CVPT)

  • Experimental
    Psychologically Informed CVPT (PIC Rehab)

    Cognitive behavioural therapy (CBT) is a form of treatment that uses multiple non-pharmacological strategies including education, behavioural and cognitive strategies to assist with decreasing symptoms. The experimental PIC Rehab arm will include principles of CBT in combination with the CVPT.

    Behavioral: Psychologically Informed CVPT (PIC) Rehab · Behavioral: Cervicovestibular Rehabilitation (CVPT)

Interventions

  • BehavioralPsychologically Informed CVPT (PIC) Rehab

    Arm Description: Cognitive behavioural therapy (CBT) is a form of treatment that uses multiple non-pharmacological strategies including education, behavioural and cognitive strategies to assist with decreasing symptoms. The experimental PIC Rehab arm will include principles of CBT in combination with the CVPT.

  • BehavioralCervicovestibular Rehabilitation (CVPT)

    Cervical and vestibular rehabilitation including individually targeted impairments based treatment techniques such as neuromuscular control, joint position sense, manual therapy, adaptation, habituation, canalith repositioning maneouvers, standing balance exercises, dynamic balance exercises, sport and work specific exercises.

06

What researchers measure

Primary outcomes

  1. Feasibility - Recruitment

    Number of participants recruited

    Time frame: From enrollment to the end of treatment at 8 weeks.

  2. Feasibility - retention rate

    Number of participants completing the trial divided by the total number of participants recruited

    Time frame: From enrolment to the end of treatment at 8 weeks

  3. Feasibility - Adverse events

    Total number of adverse events

    Time frame: From enrolment to the end of treatment at 8 weeks

  4. Feasibility - barriers and facilitators

    Barriers and facilitators to the protocol as described by the participants and the physiotherapists.

    Time frame: From enrolment to the end of treatment at 8 weeks.

  5. Feasibility - Adherence to protocol by therapist

    Adherence will be measured through voice recording review of the therapist treatment prescription in comparison to the specific group treatment protocol. The choice of treatment by the therapist will be matched to the treatment choice on the treatment protocol and rated as "yes" adheres or "no" does not adhere for each component of treatment at each recorded session. The proportion of components adhered to will be summarized.

    Time frame: From enrolment to the end of treatment at 8 weeks.

Secondary outcomes

  1. Symptom Severity Score (SSS)

    As measured on the Post Concussion Symptom Scale from the Sport Concussion Assessment tool, /132 where 0 represents no symptoms and 132 the most severe symptoms

    Time frame: Initial and 8 weeks

  2. Date of Medical Clearance to Return to Sport

    Defined as per the Amsterdam International Consensus statement (Patricios, Schneider et al 2023, page 702): "Completion of the RTS strategy with no symptoms and no clinical findings associated with the current concussion at rest and with maximal physical exertion."

    Time frame: From enrolment until treatment completion at 8 weeks

  3. Date of Return to full learn

    Defined as per the Amsterdam international consensus on concussion in sport (Patricios, Schneider et al 2023 page 702): Return to pre-injury learning activities with no new academic support, including school accommodations or learning adjustments.

    Time frame: From enrolment to the end of treatment at 8 weeks.

  4. Return to work

    Return to pre-injury occupational activities with no new support, including occupational accommodations or modifications

    Time frame: From enrolment to end of treatment at 8 weeks

Other outcomes

  1. Exploratory - Fear Avoidance Behaviour after Traumatic Brain Injury Questionnaire (FAB-TBI)

    Validated measures of fear avoidance in TBI, 0-48 with higher score representing greater fear avoidance.

    Time frame: Initial and 8 weeks

  2. Exploratory - World Health Organization Disability Assessment Schedule (WHODAS) 2.0 12 item

    WHO measure of self reported disability, scored 0-48 with higher score representing greater disability.

    Time frame: Initial and 8 weeks following treatment initiation

  3. Exploratory - Generalized Anxiety Disorder - 7

    GAD-7 to measure self reported anxiety, scored 0-21 with greater score representing anxiety

    Time frame: Initial and 8 weeks following treatment initiation

  4. Exploratory - Personal Health Questionnaire-9

    Personal Health Questionnaire - 9 to screen for depression, 0-27 with higher scores representing greater depression severity

    Time frame: Initial and 8 weeks following treatment initiation

  5. Exploratory - Test of Memory Malingering (TOMM)

    Validated test to evaluate for malingering, scores of 0-50 with scores less than 45 indicative of insufficient effort.

    Time frame: Initial to 8 weeks following treatment initiation

  6. Exploratory - Dizziness Handicap Inventory (DHI)

    25 item self report outcome measure to evaluate self perceived dizziness disability, scores range of 0-100 with greater scores indicative of greater perceived disability due to dizziness.

    Time frame: Initial to 8 weeks following treatment initiation

  7. Exploratory - Modified Dizziness Questionnaire

    Self reported characteristics of dizziness outcome including nature, duration, aggravating and easing factors with items checked as "yes" used to categorize dizziness.

    Time frame: Initial to 8 weeks following treatment initiation

  8. Exploratory - Neck Disability Index (NDI)

    Self reported outcome to describe characteristics of neck disability, scored 0-50 with greater scores indicating greater neck disability

    Time frame: Initial to 8 weeks following treatment initiation

  9. Exploratory - Patient Specific Functional Scale (PSFS)

    Self reported difficulty scale for 3-5 specific functional activities that affect the individual patient. Each individual item is rated 0-10 with greater scores indicate more difficulty with function on the specific activity and 0 representing no difficulty.

    Time frame: Initial to 8 weeks following treatment initiation

  10. Neurological Screen findings

    Any findings of cranial nerve, cerebellar or other long track signs, rated as present/absent

    Time frame: Initial and 8 weeks following treatment initiation

  11. Cervical spine range of motion

    Cervical spine range of motion full/reduced

    Time frame: Initial and 8 weeks following treatment initiation

  12. Cervical flexor endurance

    Time (seconds) the participant is able to lift and hold there head per Schneider et al 2018

    Time frame: Initial and 8 weeks following treatment initiation

  13. Cervical flexion rotation test

    Test to evaluate upper cervical spine involvement, positive/negative

    Time frame: Initial and 8 weeks following treatment initiation

  14. Craniocervical flexion test

    Evaluates craniocervical flexion ability, mmHg with a range of 20-30mmHg and greater scores indicating better performance.

    Time frame: Initial and 8 weeks following treatment initiation

  15. Manual spinal exam

    Evaluation of segmental pain rated as positive if \>3/10 pain is reproduced and limited motion

    Time frame: Initial and 8 weeks following treatment initiation

  16. Palpation for segmental tenderness

    rated as positive if reproduced familiar pain with palpation of deep structures segmentally \>3/10

    Time frame: Initial and 8 weeks following treatment initiation

  17. Extension rotation test

    Rated as positive if reproduction of familiar pain \>3/10 with extension and rotation of cervical spine

    Time frame: Initial and 8 weeks following treatment initiation

  18. Palpation of tender trigger points

    Reproduction of pain with palpation of tender trigger points yes/no

    Time frame: Initial and 8 weeks following treatment initiation

  19. Greater and lesser occipital nerve findings

    Palpation of greater and/or lesser occipital nerve reproducing familiar pain, yes/no

    Time frame: Initial and 8 weeks following treatment initiation

  20. Dix-Hallpike test

    Positional test positive for BPPV posterior or anterior canal; rated as positive/negative

    Time frame: Initial and 8 weeks following treatment initiation

  21. Nystagmus identified with fixation removed

    Tests done with videonystagmography identify nystagmus, categorized according to test findings; rated as present/absent and if present, further categorized by direction (e.g. right beat, up beat)

    Time frame: Initial and 8 weeks following treatment initiation

  22. Head thrust test

    Also called head impulse test, positive/negative to suggest potential altered vestibulo-ocular reflex function

    Time frame: Initial and 8 weeks following treatment initiation

  23. Dynamic visual acuity

    Evaluates the difference between head still and head moving using an Early Test for Diabetic Retinopathy (ETDRS) chart, logMAR with greater change indicating worse performance with head motion

    Time frame: Initial and 8 weeks following treatment initiation

  24. Vestibular Ocular Motor Screen (VOMS)

    As per Mucha et all, symptom reproduction of \>2/10 with at least two of the included 7 vestibular and oculomotor tests and/or near point of convergence \>6cm.

    Time frame: Initial and 8 weeks following treatment initiation

  25. Functional gait assessment

    Evaluates dynamic balance in a series of 10 different tests, /30 with greater scores indicating better balance performance, range 0-30

    Time frame: Initial and 8 weeks following treatment initiation

  26. Balance Error Scoring System

    Measure of standing balance on floor and on foam (where safe and appropriate) in three conditions: Romberg, tandem, single leg stance. /30 for each of foam and floor, with better balance with less errors reported (i.e. lower score), range 0-30

    Time frame: Initial and 8 weeks following treatment initiation

  27. Maximum heart rate attained on Buffalo Concussion Treadmill Test or Bike Test

    measure of physical exertion, mode of test determined by patient preference

    Time frame: Initial and 8 weeks following treatment initiation

  28. Presence of orthostatic intolerance

    symptom reproduction with change from supine to stand with at least one of drop in systolic BP of \>=20mmHg, diastolic \>=10mmHg, HR decrease or HR increases \>=30bpm (per Patricios et al 2023)

    Time frame: Initial and 8 weeks following treatment initiation

07

Study locations

1 site
  • Evidence Sport and Spinal Therapy North
    Calgary, Alberta T3B6B1, Canada
08

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Start is estimated for Jun 2026; primary completion for Sep 2026, 3 months later.

How these figures are worked out, and which studies are left out of them.

Registered
Jan 28, 2026
First posted
Feb 11, 2026
StartEst.
Jun 1, 2026
Primary completionEst.
Sep 30, 2026
CompletionEst.
Oct 30, 2026
Last update
Jun 1, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Jun 1, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT07402733
Lead sponsor
Sport Injury Prevention Research Centre
Collaborators
University of Calgary, Brain Injury Canada
Responsible party
Sponsor
First posted
Feb 11, 2026
Start date
Jun 1, 2026 (estimated)
Primary completion
Sep 30, 2026 (estimated)
Completion
Oct 30, 2026 (estimated)
Last update
Jun 1, 2026

Study contacts

Kathryn Schneider, PT, PhD
Contact
kjschnei@ucalgary.ca
+1-403-210-8951
Kathryn Schneider, PT PhD
principal investigator · University of Calgary

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in May 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion